MILISSA BURIEL: Open Payments
NPI 1770106007 · PLEASANT HILL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$928 in 59 payments from 9 companies in 2025. Trend: 2023 $247 · 2024 $545 · 2025 $928
Food & beverage: $928
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 8 | $295 |
| Exeltis, USA Inc. | 11 | $196 |
| Astellas Pharma US Inc | 7 | $150 |
| MAYNE PHARMA COMMERCIAL LLC | 20 | $129 |
| Evofem Biosciences, Inc. | 8 | $48 |
| Organon LLC | 2 | $31 |
| Dexcom, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $27 |
| MILLICENT US INC | 1 | $22 |
Products named: ZURZUVAE, Veozah, TWIRLA, SLYND, Phexxi, NEXPLANON, Dexcom G6 Transmitter, LILETTA.
Industry payments across CA — which companies pay providers there.
